Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
Pasi A. Jänne(Dana-Farber Cancer Institute), Alice T. Shaw(Massachusetts General Hospital), José Rodrigues Pereira(Instituto Brasileiro de Controle do Câncer), G. Jeannin, Johan Vansteenkiste, Carlos H. Barrios(Pontifícia Universidade Católica do Rio Grande do Sul), Fábio Franke(Hospital Universitário Cajuru), Lynda Grinsted(AstraZeneca (United Kingdom)), Victoria Zazulina(AstraZeneca (United Kingdom)), Paul D. Smith(AstraZeneca (United Kingdom)), Ian C. P. Smith(AstraZeneca (United Kingdom)), Lucio Crinò
Cited by 657
Abstract
Related Papers
No related papers found
Powered by citation graph analysis